FDA Inspection 682294 — Vitalant

Vitalant — FEI 2275064

The FDA completed an inspection of Vitalant on Sep 27, 2010 in Montvale, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 27, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Montvale, NJ (United States)

Citations

IDCFRDescription
1220221 CFR 606.170(a)Adverse Reaction - Investigations
20821 CFR 640.3(a)(1)Donor suitability procedures not followed
22421 CFR 640.4(f)Arm preparation
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.